CICLOSPORIN
Manner of administration:Oral
Restriction
Indication: The condition must be stable for the prescriber to consider the listed maximum quantity
of this medicine suitable for this patient.
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 4 | Max qty units: 120 | # of repeats: 3 | DPMQ: $108.60 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
Manner of administration:Oral
Restriction (Streamlined authority code: 6643)
Indication: Management of transplant rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)
Restriction (Streamlined authority code: 6660)
Indication: Severe atopic dermatitis
Treatment phase: Management (initiation, stabilisation and review of therapy)
Restriction (Streamlined authority code: 15360)
Indication: Severe psoriasis
Treatment phase: Management (initiation, stabilisation and review of therapy)
Restriction (Streamlined authority code: 6631)
Indication: Nephrotic syndrome
Treatment phase: Management (initiation, stabilisation and review of therapy)
Restriction (Streamlined authority code: 6638)
Indication: Severe active rheumatoid arthritis
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 4 | Max qty units: 120 | # of repeats: 5 | DPMQ: $88.16 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
Manner of administration:Oral
Restriction (Streamlined authority code: 9764)
Indication: Management of transplant rejection
Treatment phase: Management (initiation, stabilisation and review of therapy)
Restriction (Streamlined authority code: 9695)
Indication: Severe atopic dermatitis
Treatment phase: Management (initiation, stabilisation and review of therapy)
Restriction (Streamlined authority code: 15361)
Indication: Severe psoriasis
Treatment phase: Management (initiation, stabilisation and review of therapy)
Restriction (Streamlined authority code: 9694)
Indication: Nephrotic syndrome
Treatment phase: Management (initiation, stabilisation and review of therapy)
Restriction (Streamlined authority code: 9742)
Indication: Severe active rheumatoid arthritis
Treatment phase: Management (initiation, stabilisation and review of therapy)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 4 | Max qty units: 120 | # of repeats: 5 | DPMQ: $101.04 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
Manner of administration:Oral
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 3 | DPMQ: $61.20 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||